Efficacy and safety of the ICD in patients with catecholaminergic polymorphic ventricular tachycardia

Back

ESC Professional Premium Access

Efficacy and safety of the ICD in patients with catecholaminergic polymorphic ventricular tachycardia

Session: Emerging role of genetic testing for ventricular arrhythmia management

Topic: Device Treatment

Speaker: Assistant Professor A. Mazzanti (Pavia, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Assistant Professor Andrea Mazzanti

University of Pavia, Pavia (Italy)

6 presentations

0 follower

4 more presentations in this session

SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome

Speaker: Professor V. Probst (Nantes, FR)

Natural History of Patients with Typical and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia

Speaker: Doctor A. Trancuccio (Pavia, IT)

Calmodulinopathy is a common cause of critical cardiac phenotypes in fetus and infancy

Speaker: Doctor M. Fukuyama (Otsu, JP)

Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

Speaker: Miss M. Van Der Heide (Amsterdam, NL)

Access the full session

Emerging role of genetic testing for ventricular arrhythmia management

Speakers: Assistant Professor A. Mazzanti, Professor V. Probst, Doctor A. Trancuccio, Doctor M. Fukuyama, Miss M. Van Der Heide

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources